Vol 64, No 1 (2014)
Guidelines / Expert consensus
Published online: 2014-03-04
Page views
805
Article views/downloads
1644
The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations
DOI: 10.5603/NJO.2014.0008
Nowotwory. Journal of Oncology 2014;64(1):61-75.
Abstract
Lung cancer is the leading cause of cancer related death in Poland. About 85% of all lung cancer constitutes non-small cancer (NSCLC), in which the role of cytotoxic and molecularly targeted drugs is increasing. This article presents the current evidence-based recommendations for the use of these methods in clinical practice in NSCLC and malignant pleural mesothelioma.